Similarity | Rank | |
---|---|---|
Trials | 0.761 | 22492 |
trial | 0.757 | 1946 |
placebo-controlled | 0.714 | 42426 |
double-blind | 0.711 | 34234 |
randomised | 0.707 | 46929 |
randomized | 0.704 | 18214 |
multicenter | 0.701 | 69465 |
RCTs | 0.683 | 82390 |
clinical | 0.682 | 2463 |
preclinical | 0.682 | 49806 |
investigational | 0.680 | 62099 |
open-label | 0.671 | 89583 |
efficacy | 0.664 | 9929 |
pre-clinical | 0.664 | 79324 |
tribulations | 0.652 | 31535 |
studies | 0.647 | 1235 |
meta-analysis | 0.637 | 39189 |
regimens | 0.630 | 28116 |
Randomized | 0.630 | 93743 |
Herceptin | 0.625 | 84291 |
well-controlled | 0.624 | 96583 |
thalidomide | 0.619 | 97242 |
tolerability | 0.619 | 68898 |
epidemiological | 0.613 | 36173 |
investigations | 0.613 | 8006 |